Menu
Not yet recruiting NCT06573788

Multidisciplinary Prehabilitation Management Pathway and Network Platform Construction

No phase Interventional Lung Cancer Prehabilitation

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Internet + wearble device multimodal prehabilitation, traditional multimodal prehabilitation.
Who it may be relevant to
Registry conditions: Lung Cancer, Prehabilitation. Basic parameters: 18 years — 75 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

The goal of this clinical trial is to learn if "Prehabilitation model for Internet+ devices"improve patients' preoperative status and reduce the postoperative recovery time, postoperative complications，comparing to trditional prehabilitation model. The main questions it aims to answer are: 1. Does the Prehabilitation model for Internet+ devices works out? 2. Does"Prehabilitation model for Internet+ devices" better increase the patient's six-minute walk test distance? Participants will: Take Internet+devices model or traditional model to prehabilitation for 2-4weeks. Test 6MWT before operation.

Interventions

  • Behavioral Internet + wearble device multimodal prehabilitation
    Use the Prehabilitation Learning Platform to learn what to do and follow along with the videos for follow up exercises
  • Behavioral traditional multimodal prehabilitation
    The researchers used a prehabilitation manual to explain to subjects what they needed to do, and the patients went home and practiced on their own, recording the exercises daily

Primary outcome measures

  • 6 minute walking test distance, 6MWD [Time frame: About 2-4 month before surgery(When deciding on surgery), 1 day before surgery, 30 days after surgery]
Secondary outcome measures (11)
  • Length of hospitalization [Time frame: About 2-4 month before surgery(When deciding on surgery), 1 day before surgery, 30 days after surgery]
  • postoperative complication [Time frame: 30 days after surgery]
  • pulmonary function [Time frame: About 2-4 month before surgery(When deciding on surgery), 1 day before surgery, 30 days after surgery]
  • pulmonary function [Time frame: About 2-4 month before surgery(When deciding on surgery), 1 day before surgery, 30 days after surgery]
  • pulmonary function [Time frame: About 2-4 month before surgery(When deciding on surgery), 1 day before surgery, 30 days after surgery]
  • pulmonary function [Time frame: About 2-4 month before surgery(When deciding on surgery), 1 day before surgery, 30 days after surgery]
  • grip [Time frame: About 2-4 month before surgery(When deciding on surgery), 1 day before surgery, 30 days after surgery]
  • NRS2002 Nutritional Risk Screening [Time frame: About 2-4 month before surgery(When deciding on surgery), 1 day before surgery, 30 days after surgery]
  • Hospital Anxiety and Depression Scale（HADS） [Time frame: About 2-4 month before surgery(When deciding on surgery), 1 day before surgery, 30 days after surgery]
  • Quality of Recovery-15（QOR-15） [Time frame: About 2-4 month before surgery(When deciding on surgery), 1 day before surgery, 30 days after surgery]
  • World Health Organization Disability Assessment Schedule 2.0（WHODAS 2.0） [Time frame: About 2-4 month before surgery(When deciding on surgery), 1 day before surgery, 30 days after surgery]

Eligibility criteria

Inclusion criteria

  • Age: 18-75 years;
  • adults with suspected lung cancer proposed for VATS lobectomy/sublobar resection.

Exclusion criteria

  • Patient refusal;
  • ASA classification IV or higher;
  • Pre-neoadjuvant chemotherapy;
  • Inability to cooperate (psychiatric abnormalities, impaired consciousness, mental retardation);
  • Comorbidities cannot tolerate home rehabilitation or functional motor examination;
  • Inability to use a smartphone or read Chinese;
  • Average weekly moderate-intensity/high-intensity exercise of >90min/>60min.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Other

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT06573788 · ZJL-005

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗